NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $480,000 | -60.8% | 89,000 | -1.9% | 0.00% | -50.0% |
| Q4 2021 | $1,225,000 | -0.9% | 90,700 | +30.8% | 0.01% | -11.1% |
| Q3 2021 | $1,236,000 | +22.5% | 69,321 | +16.9% | 0.01% | +12.5% |
| Q2 2021 | $1,009,000 | -21.5% | 59,321 | -7.7% | 0.01% | -33.3% |
| Q1 2021 | $1,286,000 | +26.5% | 64,300 | +7.5% | 0.01% | +20.0% |
| Q4 2020 | $1,017,000 | +5.2% | 59,800 | +2.6% | 0.01% | -9.1% |
| Q3 2020 | $967,000 | -33.3% | 58,300 | -6.8% | 0.01% | -38.9% |
| Q2 2020 | $1,449,000 | +29.7% | 62,550 | 0.0% | 0.02% | +12.5% |
| Q1 2020 | $1,117,000 | -7.7% | 62,550 | +11.6% | 0.02% | +23.1% |
| Q4 2019 | $1,210,000 | +296.7% | 56,050 | +553.6% | 0.01% | +225.0% |
| Q3 2019 | $305,000 | 0.0% | 8,575 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $305,000 | +7.0% | 8,575 | +1.2% | 0.00% | 0.0% |
| Q1 2019 | $285,000 | – | 8,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |